{"title":"Adjuvant Approach to Mitigate the Adverse Effects of Cancer Treatments using Homeopathic Medicines","authors":"Arun Kumar, Mahima Sharma, Suneel Prajapati, Pankaj Gupta","doi":"10.2174/1573394718666220512163517","DOIUrl":null,"url":null,"abstract":"\n\nWorldwide, cancer patients are facing problem with life-and-death decision due to the associated severe adverse and sometimes fatal effects of existing conventional treatments. Due to the severe adverse effects of existing therapies, effective cures are progressively explored for anticancer treatment.Mostly the conventional therapies are based upon nonspecific cellular destruction properties; therefore, a treatment approach is desired to reduce the toxic burden upon normal tissues. Among all alternative medicine systems, homeopathy is one of the most popular treatment for cancer patients globally due to its minimal side effects.\n\n\n\nIn this present review, we have attempted to comprehend the literature reports of homeopathic medicine in cancer treatment.\n\n\n\nHomeopathy has also proved their adjuvant approach to minimize the symptomatic consequences of cancer. However, the insufficiency of evidence and lack of recurrence of the trials cause difficulty to draw any conclusive evidence about homeopathy as an adjuvant therapy. Based upon the etiology, genoprotective potential of homeopathic drugs was reviewed and found inconsequential evaluation and scanty literature.\n\n\n\nHence, the present review gives a comprehensive summary of retrospective studies and suggests an integration of rational drug selection, standard protocols, and quantitative analysis for revealing the differential role and plausible application of homeopathy in better cancer management.\n","PeriodicalId":43754,"journal":{"name":"Current Cancer Therapy Reviews","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cancer Therapy Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573394718666220512163517","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Worldwide, cancer patients are facing problem with life-and-death decision due to the associated severe adverse and sometimes fatal effects of existing conventional treatments. Due to the severe adverse effects of existing therapies, effective cures are progressively explored for anticancer treatment.Mostly the conventional therapies are based upon nonspecific cellular destruction properties; therefore, a treatment approach is desired to reduce the toxic burden upon normal tissues. Among all alternative medicine systems, homeopathy is one of the most popular treatment for cancer patients globally due to its minimal side effects.
In this present review, we have attempted to comprehend the literature reports of homeopathic medicine in cancer treatment.
Homeopathy has also proved their adjuvant approach to minimize the symptomatic consequences of cancer. However, the insufficiency of evidence and lack of recurrence of the trials cause difficulty to draw any conclusive evidence about homeopathy as an adjuvant therapy. Based upon the etiology, genoprotective potential of homeopathic drugs was reviewed and found inconsequential evaluation and scanty literature.
Hence, the present review gives a comprehensive summary of retrospective studies and suggests an integration of rational drug selection, standard protocols, and quantitative analysis for revealing the differential role and plausible application of homeopathy in better cancer management.
期刊介绍:
Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.